[go: up one dir, main page]

MXPA03005671A - 2-azetidinonas sustituidas con azucares utiles como agentes hipocolesterolemicos. - Google Patents

2-azetidinonas sustituidas con azucares utiles como agentes hipocolesterolemicos.

Info

Publication number
MXPA03005671A
MXPA03005671A MXPA03005671A MXPA03005671A MXPA03005671A MX PA03005671 A MXPA03005671 A MX PA03005671A MX PA03005671 A MXPA03005671 A MX PA03005671A MX PA03005671 A MXPA03005671 A MX PA03005671A MX PA03005671 A MXPA03005671 A MX PA03005671A
Authority
MX
Mexico
Prior art keywords
sugar
substituted
cholesterol
hypocholesterolemic agents
azetidinones useful
Prior art date
Application number
MXPA03005671A
Other languages
English (en)
Inventor
Ghosal Anima
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22973953&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA03005671(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of MXPA03005671A publication Critical patent/MXPA03005671A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MXPA03005671A 2000-12-20 2001-12-17 2-azetidinonas sustituidas con azucares utiles como agentes hipocolesterolemicos. MXPA03005671A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25687500P 2000-12-20 2000-12-20
PCT/US2001/049127 WO2002050090A1 (en) 2000-12-20 2001-12-17 Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents

Publications (1)

Publication Number Publication Date
MXPA03005671A true MXPA03005671A (es) 2003-10-06

Family

ID=22973953

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03005671A MXPA03005671A (es) 2000-12-20 2001-12-17 2-azetidinonas sustituidas con azucares utiles como agentes hipocolesterolemicos.

Country Status (34)

Country Link
US (1) US20020137690A1 (es)
EP (1) EP1347987B1 (es)
JP (2) JP4351842B2 (es)
KR (1) KR100883461B1 (es)
CN (1) CN100475829C (es)
AR (1) AR035611A1 (es)
AT (2) ATE279425T1 (es)
AU (2) AU2002231049B2 (es)
BR (1) BR0116212A (es)
CA (1) CA2432798C (es)
CY (1) CY1106912T1 (es)
CZ (1) CZ302193B6 (es)
DE (2) DE60129863T2 (es)
DK (2) DK1347987T3 (es)
EC (1) ECSP034659A (es)
ES (2) ES2287826T3 (es)
GE (1) GEP20053548B (es)
HU (1) HUP0302269A3 (es)
IL (1) IL155771A0 (es)
MA (1) MA26975A1 (es)
MX (1) MXPA03005671A (es)
MY (1) MY129148A (es)
NO (2) NO326981B1 (es)
NZ (1) NZ525722A (es)
PE (1) PE20020718A1 (es)
PL (1) PL208242B1 (es)
PT (2) PT1593670E (es)
RU (1) RU2297422C2 (es)
SI (2) SI1347987T1 (es)
SK (1) SK286703B6 (es)
TR (1) TR200402758T4 (es)
TW (1) TWI316942B (es)
WO (1) WO2002050090A1 (es)
ZA (1) ZA200303694B (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6982251B2 (en) 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
US7071181B2 (en) 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
SI1413331T1 (sl) 2001-01-26 2008-02-29 Schering Corp Kombinacije fenofibrata peroksisomskega proliferator aktivirajocega receptorja (PPAR) z ezetimib zaviralcem absorpcije sterola za vaskularne indikacije
RS50406B (sr) 2001-01-26 2009-12-31 Schering Corporation, Upotreba supstituisanih jedinjenja azetidinona za lečenje sitosterolemije
UA75644C2 (en) 2001-03-28 2006-05-15 Schering Corp Enantioselective synthesis of azetidinone intermediate compounds
US7053080B2 (en) 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
MXPA04002573A (es) 2001-09-21 2004-06-18 Schering Corp Tratamiento de xantoma con derivados de azetidinona como inhibidores de la absorcion de esterol.
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
GB0215579D0 (en) 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
AR040588A1 (es) 2002-07-26 2005-04-13 Schering Corp Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
EP1562582A1 (en) 2002-11-06 2005-08-17 Schering Corporation Cholesterol absorption inhibitors for the treatment of demyelination
US7459442B2 (en) 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
JP4589919B2 (ja) 2003-03-07 2010-12-01 シェーリング コーポレイション 高コレステロール血症の処置のための、置換アゼチジノン化合物、これらの処方物および使用
ES2311806T3 (es) 2003-03-07 2009-02-16 Schering Corporation Compuesto de azetidinona sustituidos, fornulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
US7192944B2 (en) 2003-03-07 2007-03-20 Schering Corp. Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
JP2005015434A (ja) 2003-06-27 2005-01-20 Kotobuki Seiyaku Kk 血清コレステロール低下剤或はアテローム性硬化症の予防又は治療剤
EP1522541A1 (en) * 2003-10-07 2005-04-13 Lipideon Biotechnology AG Novel hypocholesterolemic compounds
EP1918000A2 (en) 2003-11-05 2008-05-07 Schering Corporation Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions
ATE485267T1 (de) * 2003-12-23 2010-11-15 Astrazeneca Ab Diphenylazetidinonderivate mit die cholesterinabsorption hemmender wirkung
JP2007516287A (ja) 2003-12-23 2007-06-21 メルク　エンド　カムパニー　インコーポレーテッド 抗高コレステロール血症化合物
GB0329778D0 (en) * 2003-12-23 2004-01-28 Astrazeneca Ab Chemical compounds
MX2007003732A (es) * 2004-09-29 2007-04-23 Schering Corp Combinaciones de azetidononas sustituidas y antagonistas de receptor de canabinoide 1.
US7737155B2 (en) 2005-05-17 2010-06-15 Schering Corporation Nitrogen-containing heterocyclic compounds and methods of use thereof
AR054482A1 (es) * 2005-06-22 2007-06-27 Astrazeneca Ab Derivados de azetidinona para el tratamiento de hiperlipidemias
SA06270191B1 (ar) 2005-06-22 2010-03-29 استرازينيكا ايه بي مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
RU2008136765A (ru) * 2006-03-06 2010-04-20 Тева Фармасьютикл Индастриес Лтд. (Il) Композиции эзетимиба
AR060623A1 (es) 2006-04-27 2008-07-02 Astrazeneca Ab Compuestos derivados de 2-azetidinona y un metodo de preparacion
CN101652377A (zh) * 2007-04-02 2010-02-17 泰拉科斯有限公司 苄基化糖苷衍生物及其用法
WO2010075068A1 (en) 2008-12-16 2010-07-01 Schering Corporation Pyridopyrimidine derivatives and methods of use thereof
EP2379562A1 (en) 2008-12-16 2011-10-26 Schering Corporation Bicyclic pyranone derivatives as nicotinic acid receptor agonists
ES2487540T3 (es) * 2009-02-11 2014-08-21 Dow Agrosciences Llc Composiciones plaguicidas
WO2010100255A1 (en) 2009-03-06 2010-09-10 Lipideon Biotechnology Ag Pharmaceutical hypocholesterolemic compositions
EP2414529A2 (en) 2009-04-01 2012-02-08 Matrix Laboratories Ltd Enzymatic process for the preparation of (s)-5-(4-fluoro-phenyl)-5-hydroxy- 1morpholin-4-yl-pentan-1-one, an intermediate of ezetimibe and further conversion to ezetimibe
CN101993403B (zh) 2009-08-11 2012-07-11 浙江海正药业股份有限公司 氮杂环丁酮类化合物及医药应用
KR101102749B1 (ko) * 2009-11-30 2012-01-05 최길용 곱셈 학습기
KR20150079373A (ko) 2013-12-30 2015-07-08 한미약품 주식회사 에제티미브 및 로수바스타틴을 포함하는 경구용 복합제제
CN105055404B (zh) * 2015-08-19 2017-07-18 四川大学 Hmgcs2抑制剂在制备治疗可卡因成瘾的药物中的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3595B (en) * 1993-01-21 1995-12-27 Schering Corp Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents
US5631365A (en) * 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
US5627176A (en) * 1994-03-25 1997-05-06 Schering Corporation Substituted azetidinone compounds useful as hypocholesterolemic agents
US5633246A (en) * 1994-11-18 1997-05-27 Schering Corporation Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents
MY114803A (en) * 1995-10-31 2003-01-31 Schering Corp Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
US5756470A (en) * 1996-10-29 1998-05-26 Schering Corporation Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
AUPQ342599A0 (en) * 1999-10-14 1999-11-04 University Of Melbourne, The Conjugates and uses thereof

Also Published As

Publication number Publication date
AU3104902A (en) 2002-07-01
CN1483039A (zh) 2004-03-17
DE60129863T2 (de) 2008-04-30
HUP0302269A2 (hu) 2003-10-28
DK1593670T3 (da) 2007-11-05
ECSP034659A (es) 2003-07-25
DK1347987T3 (da) 2005-01-31
KR100883461B1 (ko) 2009-02-16
CA2432798C (en) 2007-02-27
PT1347987E (pt) 2005-01-31
HUP0302269A3 (en) 2009-08-28
WO2002050090A1 (en) 2002-06-27
PL363237A1 (en) 2004-11-15
TWI316942B (en) 2009-11-11
GEP20053548B (en) 2005-06-27
US20020137690A1 (en) 2002-09-26
JP4351842B2 (ja) 2009-10-28
CN100475829C (zh) 2009-04-08
PE20020718A1 (es) 2002-08-09
DE60106489T2 (de) 2005-10-13
SI1593670T1 (sl) 2007-12-31
MY129148A (en) 2007-03-30
ATE279425T1 (de) 2004-10-15
NO20032806D0 (no) 2003-06-19
ES2230385T3 (es) 2005-05-01
RU2297422C2 (ru) 2007-04-20
CZ20031674A3 (cs) 2003-10-15
NO20032806L (no) 2003-08-19
DE60106489D1 (de) 2004-11-18
SI1347987T1 (en) 2005-02-28
IL155771A0 (en) 2003-12-23
MA26975A1 (fr) 2004-12-20
CY1106912T1 (el) 2012-09-26
JP2009132745A (ja) 2009-06-18
HK1084945A1 (en) 2006-08-11
CA2432798A1 (en) 2002-06-27
RU2003122520A (ru) 2005-02-27
JP2004516299A (ja) 2004-06-03
NO20083737L (no) 2003-08-19
ZA200303694B (en) 2004-08-13
SK7702003A3 (en) 2003-10-07
BR0116212A (pt) 2003-12-30
KR20030063414A (ko) 2003-07-28
PT1593670E (pt) 2007-11-08
WO2002050090A8 (en) 2004-04-15
PL208242B1 (pl) 2011-04-29
DE60129863D1 (de) 2007-09-20
CZ302193B6 (cs) 2010-12-08
AR035611A1 (es) 2004-06-16
SK286703B6 (sk) 2009-03-05
ATE369334T1 (de) 2007-08-15
TR200402758T4 (tr) 2004-11-22
EP1347987A1 (en) 2003-10-01
NO326981B1 (no) 2009-03-30
NZ525722A (en) 2004-11-26
ES2287826T3 (es) 2007-12-16
EP1347987B1 (en) 2004-10-13
AU2002231049B2 (en) 2006-07-20
HK1056735A1 (en) 2004-02-27

Similar Documents

Publication Publication Date Title
PL363237A1 (en) Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
MY114803A (en) Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
WO2001081310A8 (en) 1-aroyl-piperidinyl benzamidines
MXPA04002167A (es) Inhibidores de la 17 beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades androgeno-dependientes.
PH12012501351A1 (en) Synthesis of eporthilones, intermediates thereto, analogues and uses thereof
BR0208384A (pt) Sìntese enantiosseletiva de compostos intermediários de azetidinona
CY1110361T1 (el) Φαρμακευτικες συνθεσεις ως αναστολεις διπεπτιδυλικης πεπτιδασης iv (dpp-iv)
YU58603A (sh) Kombinacija aktivatora receptora aktiviranih peroksizom proliferatora (ppar) i inhibitora apsorpcije sterola i lečenje vaskularnih indikacija
EP1499590B8 (en) Piperidine derivatives as potassium channel blockers
WO2003059898A3 (en) Eponemycin and epoxomicin analogs and uses thereof
MXPA05009503A (es) Compuestos de azetidinona sustituidos, formulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
TW200509949A (en) Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
WO2002042271A3 (en) Biphenylcarboxamides useful as lipid lowering agents
JO2390B1 (en) Diphenylcarboxamides act as lipid-lowering agents
MXPA05001712A (es) Bifenilcarboxamidas sustituidas con n-aril piperidina como inhibidores de la secrecion de apolipoproteina b.
AU2003300385A1 (en) Anticancer compounds
WO2003022844A3 (en) Synthesis of epothilones intermediates thereto and analogues thereof
AU2001246999A1 (en) New neurokinin antagonists for use as medicaments
AU2002339158A1 (en) 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors
PL365517A1 (en) Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence
AU2001244999A1 (en) Naphthamide neurokinin antagonists for use as medicaments
AU2002212241A1 (en) Method for producing chiral compounds
EP1626044A4 (en) NEW PIPERIDINE DERIVATIVE

Legal Events

Date Code Title Description
FG Grant or registration
HC Change of company name or juridical status